Affiliation:
1. Department of Pediatrics The University of Tokyo Hospital Tokyo Japan
2. Department of Pediatrics Kurashiki Central Hospital Okayama Japan
Abstract
Key Clinical MessageWhen treating patients with EBV encephalitis, the possibility of XLP should be considered. Once the diagnosis of XLP is made, aggressive treatment such as rituximab, and other immunosuppressive agents are desired for rapid transition to HSCT.
Funder
Japan Society for the Promotion of Science